Cargando…
Maternal and congenital toxoplasmosis, currently available and novel therapies in horizon
Over one billion people worldwide are predicted to harbor Toxoplasma infection frequently with unknown lifelong health consequences. Toxoplasmosis is an important cause of foodborne, inflammatory illnesses, as well as congenital abnormalities. Ubiquitous Toxoplasma has a unique tropism for central n...
Autor principal: | Oz, Helieh S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109466/ https://www.ncbi.nlm.nih.gov/pubmed/25104952 http://dx.doi.org/10.3389/fmicb.2014.00385 |
Ejemplares similares
-
Toxoplasmosis complications and novel therapeutic synergism combination of diclazuril plus atovaquone
por: Oz, Helieh S.
Publicado: (2014) -
Diclazuril Protects against Maternal Gastrointestinal Syndrome and Congenital Toxoplasmosis
por: Oz, Helieh S., et al.
Publicado: (2014) -
Toxoplasmosis, Pancreatitis, Obesity and Drug Discovery
por: Oz, Helieh S.
Publicado: (2014) -
Atovaquone ameliorate gastrointestinal Toxoplasmosis complications in a pregnancy model
por: Oz, Helieh S., et al.
Publicado: (2012) -
Macrophage Migration Inhibitory Factor (MIF) Prevents Maternal Death, but Contributes to Poor Fetal Outcome During Congenital Toxoplasmosis
por: Gomes, Angelica O., et al.
Publicado: (2018)